This website uses cookies to improve your experience. You can accept or reject analytics cookies
Influenza Pandemic Preparedness And Response Plan
Pandemic Preparedness and ResponseHealth Guideline2006
JamaicaEnglishPDF
National
AI-Generated Document Summary
Objectives
The national influenza pandemic plan provides an all-hazards framework to prevent, contain, mitigate and manage an influenza pandemic across the World Health Organization (WHO) phases, from inter-pandemic preparedness through pandemic alert, sustained transmission, recovery and deactivation. Its overarching purpose is to minimise transmission, morbidity, mortality, health-system disruption, societal disruption and economic impact while maintaining public trust through transparent and credible action.
Strengthen preparedness at national, regional, parish, institutional and community levels through coordinated contingency planning, simulation exercises, surge-capacity arrangements, stockpiles and rapid resource deployment.
Detect emerging threats early through enhanced human and animal surveillance, laboratory diagnosis, epidemiological assessment, virus characterisation and rapid notification.
Prevent animal-to-human transmission by reducing exposure to infected animals, strengthening joint animal and human health action, providing education and protective measures, and monitoring high-risk sectors.
Contain or delay human-to-human transmission during alert phases through case detection, isolation, quarantine, infection control, contact management, public health measures and targeted use of antivirals and vaccines.
Preserve health-service effectiveness during Phase 6 by optimising patient care with limited resources, maintaining essential services, managing demand, protecting health workers and deploying vaccination according to priority and availability.
Communicate timely, accurate and transparent information to the public, health workers, government agencies, partners and the media, including information on risks, uncertainty, prevention, service changes and contingency measures.
Review interventions and lessons after a pandemic or between waves, restore routine activities, and improve future preparedness and response planning.
Implementation
The plan uses a phased, multisectoral response model aligned with WHO pandemic phases and adapted nationally through continuous risk assessment. The Ministry of Health leads the health-sector response, while the Office of Disaster Preparedness and Emergency Management coordinates the wider multisectoral response under the National Disaster Plan; implementation relies on collaboration among government, health services, agriculture, laboratories, private-sector organisations, non-governmental organisations and international partners.
Activate phase-specific actions when WHO declares the relevant global phase, when national risk requires a response, or when the Ministry of Health identifies an imminent epidemic, pandemic or other threat.National phase subdivision is determined by the Chief Medical Officer in consultation with epidemiological and technical specialists and relevant Pan American Health Organization and WHO representatives.
Operate emergency command and coordination arrangements through the Ministry of Health National Emergency Operations Centre, the Ministry of Health National Influenza Pandemic Preparedness Committee, disaster-management structures and regional, parish, institutional and community plans.
Mobilise cross-sectoral partners, including agriculture, transport, trade, labour, defence, education, immigration, customs, ports, travel and tourism, to implement preparedness, containment, communications and continuity actions.
Develop and maintain operational capabilities for screening, triage, quarantine, isolation, infection control, laboratory testing, specimen transport, post-mortem management, morgue capacity, clinical management and occupational protection.
Procure and maintain pharmaceuticals, vaccines, diagnostics, reagents, personal protective equipment, equipment and other emergency supplies; prepare stockpile requirements, needs lists and budgets, although no overall budget or funding source is specified.
Notify suspected avian influenza immediately and within 24 hours of diagnosis through defined hospital, parish, regional and national reporting chains, with port quarantine officers initiating the established notification procedure.
Share surveillance findings, virus isolates and scientific information with national and international partners, including WHO, the Pan American Health Organization, the Food and Agriculture Organization and the World Organisation for Animal Health.
Monitor transmission, clinical and virological characteristics, health-system pressures, medicine and vaccine supplies, hospital and mortuary capacity, intervention effectiveness, antiviral resistance and resource needs; formal quantitative indicators and a consolidated accountability framework are not specified.
Conduct debriefings before and after deactivation, hold the Ministry of Health debriefing within seven working days of deactivation, and prepare a final report within fourteen working days of deactivation and ten working days of the debriefing meeting.
Monitoring & Evaluation
The plan establishes a phase-based monitoring and response system centred on surveillance, laboratory confirmation, risk assessment, notification, operational review and post-response learning. It specifies numerous surveillance and reporting actions, but does not establish a consolidated quantitative indicator framework, routine reporting timetable, independent audit process or formal performance-accountability mechanism.
Maintain human and animal surveillance to detect influenza-like illness, respiratory deaths, animal outbreaks, new virus subtypes, clusters, transmission patterns, disease severity, risk groups and circulating strains.
Strengthen laboratory capacity, diagnostic criteria, specimen handling, biosafety, isolate characterisation and international information-sharing to support early detection and virological surveillance.
Notify suspected avian influenza immediately and within 24 hours of diagnosis, using defined notification chains involving clinical, hospital, parish, national surveillance and emergency-management officers.
Report enhanced human and animal surveillance results daily to the Pan American Health Organization, World Health Organization, Food and Agriculture Organization, World Organisation for Animal Health and other appropriate partners during relevant alert activities.
Apply World Health Organization pandemic phases and continuous risk assessment to determine national activation, prioritise actions and guide phase-specific response measures.
Monitor medical supplies, pharmaceuticals, vaccines, infrastructure, hospital and mortuary capacity, human resources, essential-worker availability and health-system pressures as the pandemic intensifies.
Assess antiviral resistance, vaccine and antiviral safety and efficacy, treatment protocols, infection-control measures, public-health interventions and containment effectiveness.
Use preparedness checklists, simulation exercises, drills, audits and monitoring visits to identify readiness gaps, test command arrangements and improve contingency plans.
Maintain feedback mechanisms to assess public knowledge and concerns, address rumours and misinformation, and test the capacity to meet information demands from professional groups, media and the public.
Assess and publicise the current and cumulative national impact during an affected-country response, forecast trends and review interventions and the national plan using pandemic experience.
Conduct institutional, parish and regional debriefings before a Ministry of Health debriefing within seven working days of deactivation; submit preceding reports at least three days before that meeting, hold periodic debriefings during prolonged activation, and prepare a final report within fourteen working days of deactivation and ten working days of the debriefing meeting.
Costing & Financing
The plan identifies substantial resource needs for preparedness, emergency response and recovery, including stockpiles, pharmaceuticals, vaccination, laboratory supplies, workforce surge capacity and additional material resources. However, it provides no monetary budget, quantified allocation, funding source, funding gap, unit cost, resource-mobilisation target or economic assumption.
Prepare needs lists and budgets for preparedness activities, including procurement and distribution of pharmaceuticals, equipment, furniture, reagents, personal protective equipment, supplies and emergency materials.
Develop and maintain national stockpiles of antivirals, vaccines, personal protective equipment, laboratory diagnostics and other technical and emergency-response supplies.
Establish mechanisms for rapid mobilisation and deployment of domestic resources, essential workers and multisectoral response teams, including surge-capacity planning.
Review pharmaceutical and material supply requirements, vaccination logistics, cold-chain capacity, vaccination centres, staffing and arrangements to secure supplies.
Consider animal-culling compensation, antiviral availability, vaccine procurement and distribution, and national and global stockpile resources as financing and resource considerations.
Activate procedures to obtain additional resources and identify requirements for international assistance when responding to an affected-country scenario.
Ensure rational access to finite national pharmaceutical supplies and vaccine, and reassess resource requirements during subsequent pandemic waves.
Arrange additional personnel and material resources according to forecast needs and contingency plans, while replenishing medicines and supplies and renewing essential equipment between waves.